Dynamiker Biotech from TBNA Leads Major National Science and Technology Project

稿源:津滨网   编辑:王宁   2020-01-11 10:23

Recently, the National Health and Health Commission announced the National Infectious Diseases Prevention and Control Major Scientific and Technological Special Project Approval Notice 2020 (Special Letter of Health Science [2019] No. 922), a technology enterprise named Dynamiker (Tianjin) Biotechnology (hereinafter referred to as " Dynamiker") leads a project called “Development of new technologies and new products for early rapid diagnosis of invasive fungal disease infection”, which was successfully approved as a major national science and technology project.

The reporter learned that the project was led by Dynamiker Biotech and jointly applied with Shanghai Long March Hospital, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and other units. The project aims to improve the aggressiveness of AIDS and tuberculosis in China by developing new technologies and products for early and rapid joint detection of invasive fungal disease infections, and forming a precise joint diagnostic program for combined detection of fungal antigen-antibody, screening for fungal infections, and identification of genus. The level of early diagnosis and prevention of fungal infections, and the advancement of standardization of detection technology in this field will produce good economic and social benefits.